1287218-11-4

Usage

Uses

Used in Pharmaceutical Industry:
2,3-Dichloro-6-methyl-5-(trifluoromethyl)aniline is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique functional groups allow for the development of new drugs with specific therapeutic properties.
Used in Agricultural Chemical Industry:
In the agricultural sector, 2,3-Dichloro-6-methyl-5-(trifluoromethyl)aniline is utilized as a precursor in the production of agricultural chemicals. Its chemical structure contributes to the creation of effective pesticides and other agrochemicals designed to protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
2,3-Dichloro-6-methyl-5-(trifluoromethyl)aniline serves as a valuable intermediate in organic synthesis. Its reactive functional groups facilitate the formation of a wide range of organic compounds, expanding the scope of chemical research and development.
Used in Research Applications:
2,3-Dichloro-6-methyl-5-(trifluoromethyl)aniline is also employed in research settings for studying the properties and reactions of fluoroaniline derivatives. Its unique structure provides insights into the behavior of related compounds and contributes to the advancement of chemical knowledge.

Upstream product

• 115571-66-9 2,3-dichloro-5-trifluoromethyl-6-methylnitrobenzene 

Relevant academic research and scientific papers

Design, synthesis, characterization of some new 1,2,3-triazolyl chalcone derivatives as potential anti-microbial, anti-oxidant and anti-cancer agents via a Claisen-Schmidt reaction approach

The synthesis of a new series of (2E)-1-{1-[2,3-dichloro-6-methyl-5-(trifluoromethyl)phenyl]-5-methyl-1H-1,2,3-triazol-4-yl}-3-aryl prop-2-en-1-one (5a-k) and (2E)-1-{1-[2,3-dichloro-6-methyl-5-(trifluoromethyl)phenyl]-5-methyl-1H-1,2,3-triazol-4-yl}-3-(1,3-diaryl-1H-pyrazol-4-yl)prop-2-en-1-one (6a-e) were carried out via a Claisen-Schmidt condensation of 1-{1-[2,3-dichloro-6-methyl-5-(trifluoromethyl)phenyl]-5-methyl-1H-1,2,3-triazol-4-yl}ethanone (4) with different aryl and 1,3-diaryl-1H-pyrazole-4-carbaldehydes iii(a-e) in the presence of ethanol and aqueous sodium hydroxide mixture respectively. The newly synthesized compounds were characterized by IR, 1H NMR, 13C NMR, mass spectral data and elemental analysis. Further, they were screened for their in vitro anti-microbial, anti-oxidant and anti-cancer activities. Most of the synthesized compounds were displayed broad spectrum of anti-microbial, anti-oxidant activities and some of them exhibits moderate to excellent anti-cancer activities on breast cancer cell lines. Overall, this work has contributed to the development of promising leads for anti-microbial, anti-oxidant and anti-cancer activities.